Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis

Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis

Saved in:
Bibliographic Details
Published in:Annals of internal medicine Vol. 134; no. 5; pp. 426 - 427
Main Authors: VLAHAKOS, Demetrios V, MARATHIAS, K. P, KOSMAS, E. N
Format: Journal Article
Language:English
Published: Philadelphia, PA American College of Physicians 06-03-2001
Subjects:
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Female
Hematocrit
Humans
Losartan - therapeutic use
Lung Diseases, Obstructive - blood
Lung Diseases, Obstructive - complications
Lung Diseases, Obstructive - drug therapy
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Polycythemia - drug therapy
Polycythemia - etiology
Renin-Angiotensin System - drug effects
Human
Lung disease
Peptides
Respiratory disease
Hemopathy
Chemotherapy
Treatment
Losartan
Bronchus disease
Complication
Hematocrite
Angiotensin antagonist
Obstructive pulmonary disease
Angiotensin II
Mechanism of action
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0003-4819
1539-3704
DOI:10.7326/0003-4819-134-5-200103060-00022